Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines

NCT00001210 · clinicaltrials.gov ↗

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Healthy

Sponsor

National Cancer Institute (NCI)